Sign in

CIK 0001997038

Iambic Therapeutics, Inc.

Sign in to watch
Ticker
IAM
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
other
EIN
843364168
Phone
(626) 592-2520
Business address
5627 OBERLIN DRIVE, SUITE 120, SAN DIEGO, CA, 92121
  1. SCHEDULE 13G Stake Statement of Beneficial Ownership
  2. 4 Conversion 10% owner acquired 4,196,585 shares (conversion)
  3. 4 Conversion Director acquired 4,196,585 shares (conversion)
  4. 4 Conversion CFO & Chief Corp Dev Ofcr acquired 61,342 shares (conversion)
  5. 4 Conversion Director acquired 200,920 shares (conversion)
  6. 4 Open-market buy Director bought 718,750 shares at $16.00 ($11,500,000)
  7. 8-K Event Bylaws or fiscal year change · Regulation FD disclosure
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Grant or award CFO & Chief Corp Dev Ofcr acquired 28,400 shares (grant or award)
  15. 4 Grant or award Chief Scientific Officer acquired 19,500 shares (grant or award)
  16. 4 Grant or award Chief Medical Officer acquired 31,000 shares (grant or award)
  17. 4 Grant or award Chief Technology Officer acquired 132,200 shares (grant or award)
  18. 4 Grant or award Chief Executive Officer acquired 132,200 shares (grant or award)
  19. 424B4 Offering Prospectus
  20. S-8 Other Securities Offered to Employees in Benefit Plans

Page 1 of 3 · 47 filings